ACCESS launches July 5, 2026 — it will enable AI-driven chronic care only if participants can scale safe, cost-effective outcomes
Medicare’s ACCESS Model, starting July 5, 2026, shifts reimbursement from fee-for-service to outcome-based payments specifically to enable AI- and technology-supported chronic care. The program runs for a 10-year performance period, focuses on four clinical tracks, and ties recurring payments to measurable patient improvements — but its practical effect depends on whether participants can deliver scalable, safe, and cost-efficient AI-enabled care.
How ACCESS changes the financial mechanics for chronic care
ACCESS replaces activity-based billing with recurring payments that hinge on hitting patient-specific outcome targets (examples include blood pressure reduction or better mood scores). The model covers four clinical tracks — early cardio-kidney-metabolic, cardio-kidney-metabolic, musculoskeletal pain, and behavioral health (depression and anxiety) — and requires organizations to manage all qualifying conditions within a track and show risk-adjusted improvements. CMS will publicly report outcomes, introducing reputational and market pressure alongside payment incentives.
Crucially, ACCESS is not a telehealth reimbursement program or a general digital-health pilot. CMS designed it explicitly to make outcome-aligned payments that finance AI-supported workflows that Medicare’s traditional billing rules typically left unfunded. Commercial payers serving about 165 million members have committed to aligning with ACCESS’s payment approach, which raises the prospect of multi-payer adoption beyond Medicare but also sets higher expectations for demonstrable, cross-plan results.
Where ACCESS favors AI-first operators versus legacy fee-for-service providers
Under ACCESS, financial viability turns on automation and outcomes, not visit volume. That tilts advantage toward organizations that use AI and software to deliver continuous engagement and care coordination at low marginal cost, while imposing strain on traditional providers that rely on labor-intensive visit-based revenue.
| Feature | Fee-for-Service (current Medicare) | ACCESS (outcome-based) |
|---|---|---|
| Payment trigger | Encounter or procedure | Recurring payments tied to measured outcomes |
| Incentive for AI/automation | Limited; automation must be billed via narrow CPT codes | High; lower reimbursement rates favor lean, scalable tech |
| Best fit | Traditional practices with volume-based workflows | AI-first teams, virtual-first providers, tech-enabled co-management |
| Provider integration | Established referral and billing flows | Co-management fees exist, but workflows with primary care are still evolving |
Pair Team, which serves vulnerable populations, illustrates the model’s economics. CEO Neil Batlivala describes their AI voice agent, Flora, as a 24/7 engagement and coordination layer that addresses social needs (like housing instability) alongside clinical goals. Batlivala and other vendors say ACCESS’s intentionally modest payment levels are meant to reward lean, automated care rather than labor-heavy teams — a practical constraint when Medicare-scale services must remain affordable.
Data flow, integration, and the safety trade-offs to watch
ACCESS depends on feeding clinical, social, and behavioral data into systems that support automated interventions and outcome measurement. That raises two concrete limits: interoperability with incumbent electronic health records and privacy/security of sensitive federal data. CMS will collect and publish risk-adjusted outcomes, but federal systems that hold patient information have experienced security incidents in the past, which increases privacy exposure for vulnerable beneficiaries.
Operationally, the model presumes workable co-management between ACCESS organizations and primary care. CMS has introduced co-management fees to compensate coordination, but the specifics of workflows, data-sharing agreements, and clinical handoffs remain unsettled; failure to resolve them could fragment care or shift risk to under-resourced providers. The CMS Innovation Center — whose leaders include former startup founders — intentionally structured ACCESS to encourage competition, yet that regulatory design also creates pressure to demonstrate safeguards, auditability, and clinical governance at scale.
What will decide ACCESS’s trajectory in the next two to five years
The next checkpoint isn’t policy rhetoric: it’s evidence. To move beyond a niche, ACCESS participants must show within the early years of the 10-year model that AI-supported care can improve measurable outcomes, reduce avoidable costs, and integrate with traditional providers without creating new privacy or quality harms. CMS’s public outcome reports and the alignment commitments from commercial payers covering 165 million members set concrete performance and market-readiness expectations.
If early participants can demonstrate safe, scalable, and cost-effective care, ACCESS could rewire chronic care financing across payers. If they cannot, the model risks becoming a well-intentioned but limited experiment that leaves most fee-for-service incentives unchanged.
Short Q&A
When does ACCESS start and how long is the program? ACCESS launches July 5, 2026, with a 10-year performance period.
Who can join and which conditions are included? Participation is voluntary. The model covers four clinical tracks: early cardio-kidney-metabolic, cardio-kidney-metabolic, musculoskeletal pain, and behavioral health (depression and anxiety); organizations must manage all qualifying conditions in a track.
What are the immediate warning signs to watch? Early red flags include inability to demonstrate risk-adjusted outcome improvement, unresolved co-management workflows with primary care, and recurrent security incidents involving federal data systems that handle sensitive behavioral and social information.
